<SEC-DOCUMENT>0000902664-25-004599.txt : 20251028
<SEC-HEADER>0000902664-25-004599.hdr.sgml : 20251028
<ACCEPTANCE-DATETIME>20251028170017
ACCESSION NUMBER:		0000902664-25-004599
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251028
DATE AS OF CHANGE:		20251028

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Core Scientific, Inc./tx
		CENTRAL INDEX KEY:			0001839341
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40046
		FILM NUMBER:		251425691

	BUSINESS ADDRESS:	
		STREET 1:		838 WALKER ROAD
		STREET 2:		SUITE 21-2105
		CITY:			DOVER
		STATE:			DE
		ZIP:			19904
		BUSINESS PHONE:		(425) 998-5300

	MAIL ADDRESS:	
		STREET 1:		838 WALKER ROAD
		STREET 2:		SUITE 21-2105
		CITY:			DOVER
		STATE:			DE
		ZIP:			19904

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Power & Digital Infrastructure Acquisition Corp.
		DATE OF NAME CHANGE:	20210106

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Two Seas Capital LP
		CENTRAL INDEX KEY:			0001823138
		ORGANIZATION NAME:           	
		EIN:				843799363
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		32 ELM PLACE, 3RD FLOOR
		CITY:			RYE
		STATE:			NY
		ZIP:			10580
		BUSINESS PHONE:		917.536.6028

	MAIL ADDRESS:	
		STREET 1:		32 ELM PLACE, 3RD FLOOR
		CITY:			RYE
		STATE:			NY
		ZIP:			10580

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kairos Capital Management LP
		DATE OF NAME CHANGE:	20200831
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>p25-2289dfan14a.htm
<DESCRIPTION>CORE SCIENTIFIC, INC.
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">SCHEDULE 14A</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section 14(a)</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">of the Securities Exchange Act of 1934</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by the Registrant </FONT><FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by a Party other than the Registrant </FONT><FONT STYLE="font-family: Wingdings">&#254;</FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box:</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD STYLE="width: 94%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Preliminary Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Definitive Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#254;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Definitive Additional Materials</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Soliciting Material Under Rule 14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Core Scientific, Inc.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Registrant as Specified In Its Charter)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Two Seas Capital LP</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Two Seas Capital GP LLC</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Sina Toussi</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center; background-color: white">(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; background-color: white">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#254;</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">No fee required.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">o</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules&nbsp;14a-6(i)(1)&nbsp;and&nbsp;0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 4pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 4pt Calibri, Helvetica, Sans-Serif; margin: 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 23.95pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>Two Seas Capital
Expresses Enthusiasm for Core Scientific&rsquo;s Future Prospects</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-size: 12pt"><I>Issues Letter
to Shareholders Highlighting Significant Upside Potential If Proposed Sale to<BR>
CoreWeave Is Not Approved</I></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-size: 12pt"><I>Urges Shareholders
to Vote AGAINST the Ill-Advised Transaction on the GOLD Proxy Card<BR>
<B>Ahead of October 30, 2025 Special Meeting</B></I></FONT></P>

<P STYLE="font: 12pt/105% Times New Roman, Times, Serif; margin: 0">NEW YORK, October 28, 2025 -- Two Seas Capital LP (&ldquo;Two
Seas&rdquo; or &ldquo;we&rdquo;), an alternative investment management firm and one of the largest shareholders of Core Scientific,
Inc. (&ldquo;Core Scientific&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ: CORZ), today issued a letter to shareholders in
connection with its opposition to the Company&rsquo;s proposed sale to CoreWeave, Inc. (&ldquo;CoreWeave&rdquo;) (NASDAQ: CRWV) on
the terms announced on July 7, 2025.</P>

<P STYLE="font: 12pt/105% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">The full text of the letter is below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">October 28, 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Dear Fellow Core Scientific Shareholders:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">As long-standing investors in Core Scientific, we are more
enthusiastic than ever about Core Scientific&rsquo;s standalone prospects. We continue to believe that the proposed acquisition of the
Company by CoreWeave is not the best way to maximize value for Core Scientific shareholders. We will vote against the transaction and
encourage you to do the same.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Since the transaction was announced in July, investment in
AI infrastructure has accelerated, driving equity valuations of Core Scientific&rsquo;s peers to ever-greater heights. Had it traded in-line
with these peers (instead of being tethered to CoreWeave&rsquo;s underperforming stock), <B>Core Scientific&rsquo;s stock would be trading
more than twice as high as the value of the CoreWeave transaction</B>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Why would anyone vote for a transaction <B>worth a mere $16.40
per share</B>?</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Core Scientific is a best-in-class asset that we would be
proud to continue to own: it has access to low-cost power, expertise in site construction and management, a strong existing infrastructure
and an attractive future pipeline. We have full confidence in Core Scientific&rsquo;s executive management team and its ability to execute
on these advantages. We therefore fully expect Core Scientific to continue to build out its 700-megawatt pipeline, secure additional hosting
contracts for its growing HPC capacity and expand its footprint through the addition of other existing data centers and new brownfield
sites&mdash;all to the great benefit of shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">But first, we must reject the CoreWeave transaction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">The vote on that deal is scheduled for October 30, 2025. In
our view, shareholders have an easy choice to make: reject the transaction and participate in one of the most incredible growth opportunities
in the history of the capital markets or cut short Core Scientific&rsquo;s promising future to transfer significant value to CoreWeave.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">In our view, there is no reason not to play on.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">We therefore urge our fellow shareholders to join us in voting
<B>AGAINST </B>the proposed transaction on the GOLD proxy card so that Core Scientific can return its full focus and attention to the
numerous opportunities that lay ahead for one of the best assets in the rapidly growing AI landscape.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Sincerely,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Sina Toussi</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Founder, President and Chief Investment</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 25pt; text-indent: 0.5in">Officer Two Seas Capital LP</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>About Two Seas Capital LP</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Two Seas, founded in 2020 and led by Chief Investment Officer Sina
Toussi, specializes in event-driven investing anchored by rigorous fundamental research and a targeted focus on special situations. With
approximately $2.0 billion in assets under management, Two Seas&rsquo; approach is designed to uncover market inefficiencies where value
can be realized through the resolution of legal and regulatory events. The Two Seas team is highly regarded for its rigorous due diligence
and its ability to translate complex and dynamic scenarios into actionable investment opportunities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Contacts</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>Investors</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Scott Winter / Jonathan Salzberger</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Innisfree M&amp;A Incorporated</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">info@innisfreema.com</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">(212) 750-5833</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>Media</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Steve Bruce / Taylor Ingraham / Keely Gispan</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">ASC Advisors</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">twoseas@ascadvisors.com</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">(203) 992-1230</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Disclaimer</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">This press release does not constitute an offer to sell or a solicitation
of an offer to buy any of the securities described herein in any state to any person. This press release does not recommend the purchase
or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of Core Scientific or CoreWeave
will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release and the discussions
and opinions herein are for general information only, and are not intended to provide investment advice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">This press release contains forward-looking statements. Forward-looking
statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements
regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product
development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words
&ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;believes&rdquo;, &ldquo;intends&rdquo;, &ldquo;estimates&rdquo;, &ldquo;plans&rdquo;,
&ldquo;will be&rdquo; and similar expressions. Although Two Seas believes that the expectations reflected in forward-looking statements
contained herein are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks
and uncertainties&mdash;many of which are difficult to predict and are generally beyond the control of Two Seas, Core Scientific or CoreWeave&mdash;that
could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking
information and statements. In addition, the foregoing considerations and any other publicly stated risks and uncertainties should be
read in conjunction with the risks and cautionary statements discussed or identified in Core Scientific and CoreWeave&rsquo;s respective
public filings with the U.S. Securities and Exchange Commission, including those listed under &ldquo;Risk Factors&rdquo; in annual reports
on Form 10-K and quarterly reports on Form 10-Q and those related to the pending transaction involving Core Scientific and CoreWeave (the
&ldquo;Pending Transaction&rdquo;). The forward-looking statements speak only as of the date hereof and, other than as required by applicable
law, Two Seas does not undertake any obligation to update or revise any forward-looking information or statements. Certain information
included in this material is based on data obtained from sources considered to be reliable. Any analyses provided to assist the recipient
of this material in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among
alternative methodologies that produce different results. Accordingly, any analyses should not be viewed as factual and should not be
relied upon as an accurate prediction of future results. All figures are unaudited estimates and, unless required by law, are subject
to revision without notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Funds and investment vehicles (collectively, the &ldquo;Two
Seas Funds&rdquo;) managed by Two Seas currently beneficially own shares of Core Scientific and CoreWeave. The Two Seas Funds are in
the business of trading (i.e., buying and selling) securities and intend to continue trading in the securities of Core Scientific
and CoreWeave. You should assume the Two Seas Funds will from time to time sell all or a portion of their holdings of Core
Scientific and/or CoreWeave in open market transactions or otherwise, buy additional shares (in open market or privately negotiated
transactions or otherwise), or trade in options, puts, calls, swaps or other derivative instruments relating to such shares.
Consequently, Two Seas&rsquo; beneficial ownership of shares of, and/or economic interest in, Core Scientific and/or CoreWeave may
vary over time depending on various factors, with or without regard to Two Seas&rsquo; views of the Pending Transaction or Core
Scientific and/or CoreWeave&rsquo;s respective businesses, prospects, or valuations (including the market price of Core Scientific
and/or CoreWeave shares), including, without limitation, other investment opportunities available to Two Seas, concentration of
positions in the portfolios managed by Two Seas, conditions in the securities markets, and general economic and industry conditions.
Without limiting the generality of the foregoing, in the event of a change in Core Scientific and/or CoreWeave&rsquo;s respective
share prices on or following the date hereof, the Two Seas Funds may buy additional shares or sell all or a portion of their
holdings of Core Scientific and/or CoreWeave (including, in each case, by trading in options, puts, calls, swaps, or other
derivative instruments). Two Seas also reserves the right to change the opinions expressed herein and its intentions with respect to
its investments in Core Scientific and CoreWeave, and to take any actions with respect to its investments in Core Scientific and
CoreWeave as it may deem appropriate, and disclaims any obligation to notify the market or any other party of any such changes or
actions, except as required by law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Important Information</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Two Seas, Two Seas Capital GP LLC (&ldquo;Two Seas GP&rdquo;), and
Sina Toussi (&ldquo;Mr. Toussi&rdquo; and, together with Two Seas and Two Seas GP, the &ldquo;Participants&rdquo;) have filed a definitive
proxy statement and GOLD proxy card (the &ldquo;Proxy Statement&rdquo;) with the SEC on September 29, 2025 to be used to solicit proxies
for votes against the proposed acquisition of Core Scientific by CoreWeave at the upcoming special meeting of the Company&rsquo;s shareholders.
THE PARTICIPANTS STRONGLY ADVISE ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS BECAUSE THEY CONTAIN
IMPORTANT INFORMATION. SUCH PROXY MATERIALS ARE AVAILABLE AT NO CHARGE ON THE SEC&rsquo;S WEBSITE AT HTTP://WWW.SEC.GOV. IN ADDITION,
THE PARTICIPANTS WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE UPON REQUEST. Additional information about the Participants
and a description of their direct or indirect interests by security holdings or otherwise can be found in Exhibit 2 of the Schedule 14A
filed by Two Seas with the <FONT STYLE="font-variant: small-caps">SEC</FONT> on October 10, 2025.</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "A 1 # 2(  A$! Q$!_\0
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MBB@ HHHH **** "BBB@ KG?&WA"T\>>%+_P_>RW$%I>Q>4TEK)Y<J?0UT5%
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MCG\JZ"BBO/-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "DI:0T ? O_!7[_DB?@?\ [&?_ -M+JORBK]7?^"OW_)$_ _\
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M.T^UTFU%M9V\5I;QCB*&,1QT^\L[74+?[/<11S1'_EG)5NB@!E/HHH ****
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MBOO_ (U7T]X=UZR\5:#8ZOILWG:?>Q1W-O)L*?NS@BHY -NBBN+^)GQ(\/\
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MUM#\/_#(TKPO\*I=,_LNV^R2W>I7_G>5Y0\OS/TK;_EV!]>?\(SI'_0&LO\
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21110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  R *P# 2(  A$! Q$!_\0
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M!@5U_P /_C!X1^*D4\GA76H=92 [97A#JH^F1S5^Z\%^#M)A,UQHNBVT:_\
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M?!3X=>%(=+$T?AC1DEV#]XNGQ!OSVT44 >PPV=O8PE+:".W3^[$@4?I4U%%
7!3Z** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
